An integrated people-centric, preventive, and personalized healthcare system.

We are building a well-rounded portfolio of revolutionary companies that have the potential to disrupt the global market.

Private markets play a pivotal role in driving healthcare transformation. With the advent of the post-COVID era, we are witnessing a decline in healthcare technology costs and an unprecedented surge in data availability. These factors fuel an accelerated innovation cycle that expands access to quality patient care.

We’re at the front lines of this transformation by investing in pioneering early-stage companies in the US and Europe.

Our investment scope includes Pre-Seed, Seed, and Series A rounds.

We carefully align our investments with market dynamics and the prevailing consumer zeitgeist.